Drug intelligence / Profile preview

[18F]BIBD-239

Development stage
Unknown
Lead developer
Capital Medical University
Modality
Positron Emitters → Radiopharmaceuticals
01

Overview

[18F]BIBD-239: sourced facts only. name: "Conclusively, [18F]BIBD-239, similar to ER176 with low polymorphism sensitivity, has simple labeling conditions, high labeling yield, high affinity, and high specificity for TSPO, and it is planned for further evaluation in higher species." [PMID:35671264]; target: "Conclusively, [18F]BIBD-239, similar to ER176 with low polymorphism sensitivity, has simple labeling conditions, high labeling yield, high affinity, and high specificity for TSPO, and it is planned for further evaluation in higher species." [PMID:35671264]; developer: "Beijing Institute of Brain Disorders, Laboratory of Brain Disorders, Ministry of Science and Technology, Collaborative Innovation Center for Brain Disorders, Capital Medical University, Beijing 100069, China." [PMID:35671264]; stage: "Additionally, [18F]BIBD-239 provided clear tumor PET images in a GL261 glioma model." [PMID:35671264]

02

Targets

TSPO (Translocator Protein (18 kDa))

Beyond the preview

Go deeper on [18F]BIBD-239.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on [18F]BIBD-239.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call